GUGGENHIME ANDREW sold PCVX
August 3, 2026 · Form 4 insider transaction
GUGGENHIME ANDREW sold 6,956 shares of Vaxcyte, Inc. at $53.76 per share, a transaction worth $374.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
6,956
Price
$53.76
Total value
$374.0K
InsiderGUGGENHIME ANDREW
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 3, 2026
Filing dateAugust 5, 2026
Shares owned after108,220
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.; The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.